Circulatory effects of oxprenolol, a new beta-adrenergic blocking agent.
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology / Q000627:therapeutic use; D000704:Analysis of Variance; D001024:Aortic Valve Stenosis; D001775:Blood Circulation / Q000187:drug effects*; D001794:Blood Pressure / Q000187:drug effects*; D006328:Cardiac Catheterization; D002302:Cardiac Output / Q000187:drug effects*; D002312:Cardiomyopathy, Hypertrophic; D002986:Clinical Trials as Topic; D003327:Coronary Disease / Q000503:physiopathology; D003331:Coronary Vessels / Q000503:physiopathology; D003864:Depression, Chemical; D004395:Dye Dilution Technique; D006321:Heart / Q000503:physiopathology; D006339:Heart Rate / Q000187:drug effects*; D006801:Humans; D008946:Mitral Valve Stenosis; D009119:Muscle Contraction / Q000187:drug effects; D009206:Myocardium; D013268:Stimulation, Chemical; D013565:Sympatholytics / Q000494:pharmacology*; D014655:Vascular Resistance / Q000187:drug effects*
D000319:Adrenergic beta-Antagonists; D013565:Sympatholytics